IFP Advisors’s TransCode Therapeutics RNAZ Stock Holding History

IFP Advisors’s Portfolio RNAZ Stock Details RNAZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$13	Buy	+8	New	+$33	﹤0.01%	5161

Other funds holding RNAZ

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

IFP Advisors's RNAZ Position: Q3 2026 in Review

IFP Advisors opened a new position in TransCode Therapeutics (RNAZ) in Q3 2026: 8 shares worth $13. The stake represents ﹤0.01% of the portfolio and ranks #5161 among its holdings.

2 funds tracked by Wall St. Rank hold RNAZ as of Q3 2026.

IFP Advisors held 8 shares of TransCode Therapeutics worth $13 as of Q3 2026.
TransCode Therapeutics was a new IFP Advisors position in Q3 2026.
TransCode Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #5161 holding.
2 funds tracked by Wall St. Rank held TransCode Therapeutics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.